Clinical Trials Network: Pacific Northwest Node

临床试验网络：太平洋西北节点

• 批准号: 7497398
• 负责人: DENNIS Michael DONOVAN
• 金额: $ 6.3万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-01-10 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7497398
• 关键词: Alaska; Alcohols; Area; Behavioral; Clinical Research; Clinical Trials Network; Communities; Country; Drug abuse; Drug usage; Effectiveness; Ensure; Evidence based intervention; Future; Health Personnel; Health Priorities; Housing; Institutes; Interdisciplinary Study; Intervention; Intervention Trial; Leadership; Mission; Multi-Institutional Clinical Trial; National Institute of Drug Abuse; Nature; Numbers; Pacific Northwest; Patients; Performance; Pharmacological Treatment; Pharmacotherapy; Play; Policy Maker; Population; Progress Reports; Protocols documentation; Public Health; Range; Recommendation; Reporting; Research; Research Infrastructure; Research Personnel; Research Training; Role; Science; Substance abuse problem; Time; Universities; Washington; Work; base; dissemination research; experience; improved; programs; research study; response; success; treatment program

This is a competing renewal application for the Pacific Northwest (PNW) Node, which joined the NIDA National Drug Abuse Treatment Clinical Trials Network (CTN) in January, 2001. Our primary aim is to continue our active support of the CTN's mission, to "improve the quality of drug abuse treatmentthroughout the country using science as the vehicle" by conducting studies of behavioral, pharmacological, and ntegrated behavioral-pharmacological treatment interventions in rigorous, multi-site clinical trials to determine their effectiveness across a broad range of CTP settings and diversified patient populations and ensuring the transfer of research results to treatment providers. In order to effectively meet these objectives, the (PNW) Node proposes to: Maintain an effective, bidirectional partnership and working relationship among researchers, treatment providers, and policy makers Maintain and expand a highly successful and well-established treatment research infrastructure within the Node Expand the Node's geographical reach by incorporating a community-based treatment program (CTP) from Alaska, also broadening the ethnic diversity within the Node Enhance the Node's capacity to conduct pharmacotherapy trials and respond more rapidly to emerging public health priorities by adding a larger, highly research-experiencedCTP ¿ Broaden and deepen the clinical research expertise of the Node by adding a number of affiliated investigators who bring a wealth of experience from prior intervention trials on topic areas directly relevant to the CTN We have successfully contributed to the CTN's mission over the past 6 years and anticipate continuing to do so in the future. From a public health perspective, our continued success in conducting such research and dissemination as part of the CTN will facilitate empirically supported, evidence-based interventions being implemented in community-based treatment programs, with a resultant improvement in the quality and effectiveness of substance abuse treatment.

这是一个竞争性的更新申请，为太平洋西北（PNW）节点，其中加入了NIDA 国家药物滥用治疗临床试验网络（CTN），2001年1月。我们的主要目标是 继续积极支持CTN的使命，即“全面提高药物滥用治疗的质量 这个国家以科学为载体”，通过进行行为，药理学和 在严格的多中心临床试验中整合行为药理学治疗干预， 确定其在广泛的CTP设置和多样化的患者人群中的有效性， 确保将研究成果转让给治疗提供者。 为了有效实现这些目标，太平洋西北地区联络点建议： 在研究人员、治疗人员和研究人员之间保持有效的、双向的伙伴关系和工作关系。 供应商和政策制定者 维持和扩大一个非常成功和完善的治疗研究基础设施， 节点 通过纳入基于社区的治疗计划（CTP），扩大该节点的地理覆盖范围 从阿拉斯加，也扩大了节点内的种族多样性 加强该节点进行药物治疗试验的能力，并更迅速地应对新出现的 通过增加一个更大的，高度研究经验丰富的CTP， 通过增加一些附属机构，扩大和深化节点的临床研究专业知识 研究者从先前的干预试验中直接获得丰富的经验， 与CTN相关 在过去的6年里，我们成功地为CTN的使命做出了贡献，并希望继续这样做。 所以在未来。从公共卫生的角度来看，我们在开展此类研究方面的持续成功， 作为CTN的一部分，传播将促进经验支持，基于证据的干预措施， 在以社区为基础的治疗方案中实施，从而提高质量， 药物滥用治疗的有效性。